Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippos Anagnostakis

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Neuropharmacology|January 20, 2022
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in GliomasFilippos Anagnostakis, Christina Piperi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 14, 2026
Long-term Risk of Prediabetes and Type 2 Diabetes Following SARS-CoV-2 Infection: A Nationwide Cohort StudyFilippos Anagnostakis, Michail Kokkorakis
International Journal of Molecular Sciences|June 10, 2023
Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive ReviewFilippos Anagnostakis, Michail Kokkorakis, Mariam Markouli, et al.
Biomedicines|May 25, 2024
Signatures and Discriminative Abilities of Multi-Omics between States of Cognitive DeclineFilippos Anagnostakis, Michail Kokkorakis, Keenan A Walker, et al.
Diabetes Research and Clinical Practice|January 27, 2026
Glucagon-like peptide-1 receptor agonists risk for anxiety and depression risk, and suicidality: a large cohort studyFilippos Anagnostakis, Michail Kokkorakis, Georgia Anastasiou, et al.
Diabetes, Obesity & Metabolism|November 27, 2025
Comparative effectiveness of SGLT2 sodium-glucose cotransporter-2 inhibitors and GLP-1 glucagon-like peptide-1 receptor agonists for incident dementia: A retrospective multicohort studyFilippos Anagnostakis, Michail Kokkorakis, Shrihari Nagarajan, et al.
Nature Communications|May 26, 2025
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk, Filippos Anagnostakis, Sarah Ko, et al.
Nature Biomedical Engineering|October 1, 2025
Brain-heart-eye axis revealed by multi-organ imaging genetics and proteomics, Aleix Boquet-Pujadas, Filippos Anagnostakis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Impact of cardiometabolic conditions on the progression from mild cognitive impairment to dementia: A large cohort studyFilippos Anagnostakis, Michail Kokkorakis, Christos Asvestis, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Brain-heart-eye axis revealed by multi-organ imaging, genetics and proteomics, Aleix Boquet-Pujadas, Filippos Anagnostakis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Neuropharmacology|January 20, 2022
Targeting Options of Tumor-Associated Macrophages (TAM) Activity in GliomasFilippos Anagnostakis, Christina Piperi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 14, 2026
Long-term Risk of Prediabetes and Type 2 Diabetes Following SARS-CoV-2 Infection: A Nationwide Cohort StudyFilippos Anagnostakis, Michail Kokkorakis
International Journal of Molecular Sciences|June 10, 2023
Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive ReviewFilippos Anagnostakis, Michail Kokkorakis, Mariam Markouli, et al.
Biomedicines|May 25, 2024
Signatures and Discriminative Abilities of Multi-Omics between States of Cognitive DeclineFilippos Anagnostakis, Michail Kokkorakis, Keenan A Walker, et al.
Diabetes Research and Clinical Practice|January 27, 2026
Glucagon-like peptide-1 receptor agonists risk for anxiety and depression risk, and suicidality: a large cohort studyFilippos Anagnostakis, Michail Kokkorakis, Georgia Anastasiou, et al.
Diabetes, Obesity & Metabolism|November 27, 2025
Comparative effectiveness of SGLT2 sodium-glucose cotransporter-2 inhibitors and GLP-1 glucagon-like peptide-1 receptor agonists for incident dementia: A retrospective multicohort studyFilippos Anagnostakis, Michail Kokkorakis, Shrihari Nagarajan, et al.
Nature Communications|May 26, 2025
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk, Filippos Anagnostakis, Sarah Ko, et al.
Nature Biomedical Engineering|October 1, 2025
Brain-heart-eye axis revealed by multi-organ imaging genetics and proteomics, Aleix Boquet-Pujadas, Filippos Anagnostakis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Impact of cardiometabolic conditions on the progression from mild cognitive impairment to dementia: A large cohort studyFilippos Anagnostakis, Michail Kokkorakis, Christos Asvestis, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Brain-heart-eye axis revealed by multi-organ imaging, genetics and proteomics, Aleix Boquet-Pujadas, Filippos Anagnostakis, et al.
Pageof 2